journal article·2026-07

Distinct motility and pro-fibrotic effect of renal tubule-derived extracellular vesicles in fibrotic extracellular matrix

An-Ran Shen, Tian Gao, Yu-Qi Fu, Hao-Qi Zhu, Yan Bao, Ning Li, Tao-Tao Tang, Yi Cao, Bi-Cheng Liu, Bin Xue, Lin-Li Lv

Publisher page

Abstract

Extracellular vesicles (EVs) facilitate intercellular communication by traversing the extracellular matrix (ECM). However, their motility within fibrotic ECM and its role in fibrosis development remain unclear. We engineered stress-relaxing (SR) hydrogels of tunable stiffness (2, 50 kPa) through dynamic crosslinking of short peptide (WGG(KA)) and heparin to mimic normal and fibrotic ECM. Super-resolution nanoimaging and quantitative three dimensional (3D) single-particle tracking (SPT) of single EV were performed, and the motion dynamics was quantified. The interplay between EVs and ECM was further investigated, particularly its effects on fibroblast activation and renal fibrosis. It was identified that both normal and fibrotic kidney-derived EVs exhibited confined Brownian-like motion according to 3D SPT, with enhanced mobility in the stiffer (50 kPa) hydrogel. Notably, fibrotic tubule-derived EVs carried higher levels of integrin β6 (ITGB6), which reduced their mobility within the hydrogel-based ECM mimic, as confirmed by the restoration of motility upon ITGB6 blocking or digestion. This suggested that EV motility may be influenced by the interplay between ECM stiffness and the intrinsic properties of the EVs. Furthermore, enrichment of ITGB6 on fibrotic tubule-derived EVs promotes local retention, thereby increasing EV-fibroblast interaction and profibrotic signaling. This indicated the underappreciated role of EV in fibrosis related to its motility and its interplay with fibroblast in fibrotic niche. Our study provides new insights into the mechano-dependent mechanisms governing EV motility within the fibrotic ECM. STATEMENT OF SIGNIFICANCE: Extracellular vesicles (EVs) play key roles in cell communication, but how they move through fibrotic tissue remains poorly understood. This study reveals that kidney-derived EVs exhibit confined Brownian-like motion within engineered hydrogels mimicking fibrotic extracellular matrix. We found that EVs from fibrotic tubules carry elevated integrin β6, which restricts their mobility and promotes pro-fibrotic signaling by increasing EV-fibroblast interaction. Our study provides new insights into the mechano-dependent mechanisms governing EV motility within the fibrotic ECM. This work provide a biophysical perspective for understanding EVs mediated pathological communication in fibrosis.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Extracellular vesicles in disease · Tissue Engineering and Regenerative Medicine · Dialysis and Renal Disease Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
1. Extracellular vesicle-matrix interactions10.1038/s41578-023-00551-3 ↗
2. Remodelling the extracellular matrix in development and disease10.1038/nrm3904 ↗
3. The fibrogenic niche in kidney fibrosis: components and mechanisms10.1038/s41581-022-00590-z ↗
4. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys10.7150/thno.62820 ↗
5. TGF-beta1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis10.1681/ASN.2012101031 ↗
6. Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the lung10.1016/j.cell.2018.12.002 ↗
7. Stiff matrix induces exosome secretion to promote tumour growth10.1038/s41556-023-01092-1 ↗
8. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 202310.1016/S0140-6736(25)01853-7 ↗
9. Fibrosis: from mechanisms to medicines10.1038/s41586-020-2938-9 ↗
10. Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury10.1038/s41418-019-0349-y ↗
11. Tumour exosome integrins determine organotropic metastasis10.1038/nature15756 ↗
12. Directional cell movement through tissues is controlled by exosome secretion10.1038/ncomms8164 ↗
13. Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs
14. Exploring the role of ITGB6: fibrosis, cancer, and other diseases10.1007/s10495-023-01921-6 ↗
15. Effects of extracellular matrix viscoelasticity on cellular behaviour10.1038/s41586-020-2612-2 ↗
16. Viscoelastic mechanics: from pathology and cell fate to tissue regeneration biomaterial development10.1021/acsami.4c18174 ↗
17. Harnessing extracellular vesicle heterogeneity for diagnostic and therapeutic applications10.1038/s41565-024-01774-3 ↗
18. Using single-vesicle technologies to unravel the heterogeneity of extracellular vesicles10.1038/s41596-021-00551-z ↗
19. Unveiling heterogeneity: innovations and challenges in single-vesicle analysis for clinical translation10.1002/jev2.70209 ↗
20. Single urinary extracellular vesicle proteomics identifies complement receptor CD35 as a biomarker for sepsis-associated acute kidney injury10.1038/s41467-025-62229-4 ↗
21. Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 210.1016/j.cell.2025.01.025 ↗
22. Tubular epithelial cells-derived small extracellular vesicle-VEGF-A promotes peritubular capillary repair in ischemic kidney injury10.1038/s41536-022-00268-x ↗
23. Matrix mechanics and water permeation regulate extracellular vesicle transport10.1038/s41565-020-0636-2 ↗
24. Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer10.3402/jev.v4.25530 ↗
25. Magnetic resonance elastography for evaluation of renal parenchyma in chronic kidney disease: a pilot study10.1007/s11547-020-01210-1 ↗
26. The kidney matrisome in health, aging, and disease10.1016/j.kint.2022.06.029 ↗
27. ARFI-based tissue elasticity quantification in comparison to histology for the diagnosis of renal transplant fibrosis10.3233/CH-2010-1340 ↗
28. Causal contributors to tissue stiffness and clinical relevance in urology10.1038/s42003-021-02539-7 ↗
29. Noninvasive evaluation of renal allograft fibrosis by transient elastography–a pilot study
30. Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation10.1126/science.1240104 ↗
31. Yap/taz deletion in gli(+) cell-derived myofibroblasts attenuates fibrosis10.1681/ASN.2015121354 ↗
32. Hydrogels with tunable stress relaxation regulate stem cell fate and activity10.1038/nmat4489 ↗
33. Latent TGF-beta structure and activation10.1038/nature10152 ↗
34. Fibroblast and myofibroblast activation in normal tissue repair and fibrosis10.1038/s41580-024-00716-0 ↗
35. Hopping diffusion of nanoparticles in polymer matrices10.1021/ma501608x ↗
36. Exploring the spatial limits of extracellular vesicles-mediated intercellular communication10.1002/jev2.70169 ↗
37. Competition between bending and internal pressure governs the mechanics of fluid nanovesicles10.1021/acsnano.6b07302 ↗
38. Nanoconfined polymerization limits crack propagation in hysteresis-free gels10.1038/s41563-023-01697-9 ↗
39. Dynamics of nanoparticles in polydisperse polymer networks: from free diffusion to hopping10.1021/acs.macromol.1c01394 ↗
40. Enhanced heterogeneous diffusion of nanoparticles in semiflexible networks10.1021/acsnano.0c08877 ↗
41. Extracellular vesicles as theranostic tools in kidney disease10.2215/CJN.16751221 ↗
42. Engineered exosome for drug delivery: recent development and clinical applications10.2147/IJN.S444582 ↗
43. Progress in drug delivery system for fibrosis therapy
44. Convection and extracellular matrix binding control interstitial transport of extracellular vesicles10.1002/jev2.12323 ↗
45. TGF-beta activation and function in immunity10.1146/annurev-immunol-032713-120257 ↗